Compliance with the EU Ecodesign Directive is driving pharmaceutical manufacturing facilities’ energy consumption up, not down as intended. Jim Heemer and Hugh Reynolds of Jacobs explain the background to this anomaly.
Gero Lustig, global business manager Pharma and Life Sciences at ABB explains how using a digital twin of existing machines can determine how best to implement shop floor integration prior to installation.
Getting drugs with unstable characteristics to the patient is a complicated process. One company believes it may have the solution, as Sylvie Ponlot from Technoflex explains.
Rod Schregardus, supply chain technology specialist at Access Group, discusses the role of advanced planning and scheduling (APS) systems in pharmaceuticals manufacturing.
EPM editor Reece Armstrong caught up with Frederique Bordes-Picard, business development for innovative products capsule delivery solutions at Lonza to learn more about the company's new dry-powder inhalation capsule.
George Walker, managing director of Novotek UK and Ireland, explains how the pharmaceutical industry can increase asset use and improve lifecycles by becoming more flexible.
The latest episode of The MedTalk Podcast has landed with the editors discussing all things digital health, a recent trip to pharmacy John Bell & Croyden and how a quirky wearable could let you take control of your dreams.
Clive Glover, strategy director and cell and gene therapy lead at Pall Corporation, explains why we need to take a more holistic approach to gene therapy manufacturing processes.
Dr Anthony Qu, vice president of scientific affairs at Cambrex and Dr Yanjun Zhao, market intelligence manager examine the complexities of developing oral doses for the paediatric market.
Justin Schroeder, vice president for global programme management at PCI Pharma Services, looks at how to support the delivery of biologics through automated inspection systems.
